InsidersTradesSigma
OKYO Pharma Ltd Stock: price and management transactions · United States · SEC (Form 4)
Follow the OKYO Pharma Ltd stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, OKYO Pharma Ltd has recorded 9 reports. Market capitalisation: €82.4m. The latest transaction was reported on 10 June 2026 (Attribution). Among the most active insiders: CERRONE GABRIELE M. All data is openly available.
9
Insider Decl.
0
Thresholds
€812,627
6 ops.
Buy Volume
·
0 ops.
Sell Volume
62Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 June 2026
Declarations9 total
300,000 sharesCOMMON STOCKSEC:0001493152-26-028117:0
499,468 shares@ US$1.5045.5% of flowOrdinary SharesSEC:0001493152-23-038854:0
70,071 shares@ US$1.506.4% of flowOrdinary SharesSEC:0001493152-23-038854:1
16,670 shares@ US$1.50100.0% of flowOrdinary SharesSEC:0001493152-23-034486:0
Ideal exit: 11 Jun 2024 (T+270)
5,800,000 shares@ US$0.0760.50% mcap56.2% of flowOrdinary SharesSEC:0001493152-22-014552:0
Ideal exit: 13 Feb 2023 (T+270)
12,500 shares@ US$4.000.057% mcap100.0% of flowAmerican Depositary SharesSEC:0001493152-22-014438:0
Ideal exit: 13 Feb 2023 (T+270)
37,500 shares@ US$4.000.17% mcap19.1% of flowAmerican Depositary SharesSEC:0001493152-22-014437:0
Ideal exit: 13 Feb 2023 (T+270)
25,000 shares@ US$3.870.11% mcap12.4% of flowAmerican Depositary SharesSEC:0001493152-22-014299:0
Ideal exit: 11 Feb 2023 (T+270)
1,625,000 shares@ US$0.05950.11% mcap12.4% of flowOrdinary SharesSEC:0001493152-22-014284:0
Ideal exit: 11 Feb 2023 (T+270)
9 of 9 declarations
About OKYO Pharma Ltd
OKYO Pharma Ltd is a biopharmaceutical company focused on developing treatments for inflammatory diseases and eye disorders. It is listed on NASDAQ under the symbol OKYO.